99 results
8-K
EX-99.1
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
27 Dec 23
Completion of Acquisition or Disposition of Assets
8:25pm
(NCT05607615) based on encouraging data from an Expanded Access program for Alzheimer’s disease (NCT03624842). Additional indications for the active ingredient
425
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
18 Dec 23
Business combination disclosure
6:02am
referred to below, conducting presentations, and granting access to virtual data rooms. None of these discussions had yet matured to term sheets
8-K
5636bdftfi2b6
18 Dec 23
Other Events
6:01am
424B3
bjt8r2a6mn
21 Nov 23
Prospectus supplement
9:15am
S-4/A
smsjij4
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
S-4
g5ezqik
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
425
EX-2.1
wvgkno2ae7r2vk
21 Sep 23
Business combination disclosure
4:28pm
425
EX-99.1
c8vkqo85ub7uv
21 Sep 23
Business combination disclosure
4:28pm
8-K
EX-2.1
dj211prk9r6mskzbo
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
4:28pm
8-K
EX-99.1
2inksq
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
4:28pm
8-K
EX-10.2
u8w e8oy8m025ypp
4 May 23
Unregistered Sales of Equity Securities
3:42pm